Medifast, Inc. (LON:0K05)
Market Cap | 102.83M |
Revenue (ttm) | 350.68M |
Net Income (ttm) | 2.65M |
Shares Out | n/a |
EPS (ttm) | 0.24 |
PE Ratio | 38.75 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 23 |
Average Volume | 179 |
Open | 14.01 |
Previous Close | 13.92 |
Day's Range | 13.99 - 14.01 |
52-Week Range | 11.74 - 22.25 |
Beta | 0.84 |
RSI | 52.19 |
Earnings Date | Nov 3, 2025 |
About Medifast
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou... [Read more]
Financial Performance
In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.
Financial numbers in USD Financial StatementsNews
Medifast signals limited use of promotions and unveils Premier+ pricing to drive coach retention
Medifast, Inc. (MED) Q2 2025 Earnings Call Transcript

Medifast (MED) Q2 Revenue Falls 37%
Medifast GAAP EPS of $0.22 beats by $0.41, revenue of $105.6M beats by $3.8M

Medifast Announces Second Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter...
Medifast (MED) Earnings Report: Anticipated Decline in Q2 Performance
Medifast (MED) Earnings Report: Anticipated Decline in Q2 Performance
Medifast Q2 2025 Earnings Preview

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quart...

Medifast: Coach Surge Fuels Growth
We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core contrarian trade for outsized upside.
Medifast projects Q2 2025 revenue of $85M-$105M amid coach strategy enhancements
Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript
Medifast, Inc. 2025 Q1 - Results - Earnings Call Presentation

Medifast Announces First Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...
Earnings Scheduled For April 28, 2025
Companies Reporting Before The Bell • Guardforce AI Co (NASDAQ: GFAI) is projected to report earnings for its Fiscal Year 2024. • Bright Scholar Education (NYSE: BEDU) is expected to report earnings...

Uncovering Potential: Medifast's Earnings Preview
Medifast (NYSE: MED) will release its quarterly earnings report on Monday, 2025-04-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Medifast to report an earni...

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as ...

How Is The Market Feeling About Medifast?
Medifast's (NYSE: MED) short percent of float has risen 3.91% since its last report. The company recently reported that it has 1.39 million shares sold short , which is 19.38% of all regular shares t...
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
Medifast Inc (MED) Q4 Earnings: EPS of $0.07 Beats Estimate, Revenue at $119M Surpasses Expectations
Medifast Inc (MED) Q4 Earnings: EPS of $0.07 Beats Estimate, Revenue at $119M Surpasses Expectations
Medifast, Inc. 2024 Q4 - Results - Earnings Call Presentation
Medifast Non-GAAP EPS of $0.10 beats by $0.26, revenue of $119M beats by $4.75M

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter...

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourt...

Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround
Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration with LifeMD.